Clinical Trials Directory

Trials / Completed

CompletedNCT01099865

High-sensitivity C-reactive Protein and United Kingdom Prospective Diabetes Study (UKPDS) Risk Score in Type 2 Diabetes

High-sensitivity C-reactive Protein and UKPDS Risk Score in Type 2 Diabetes: Nalysis With 18F-Fluorodeoxyglucose Positron Emission Tomography

Status
Completed
Phase
Study type
Observational
Enrollment
56 (actual)
Sponsor
Korea University · Academic / Other
Sex
All
Age
16 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The UKPDS risk score is recommended to assess global risk for future coronary heart disease (CHD) events in primary prevention. Recently, high-sensitivity C-reactive protein (hsCRP) has emerged as a strong independent risk factor for CHD. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a promising imaging technique for the evaluation of vascular inflammation that reflects vulnerable atherosclerotic plaque.

Conditions

Timeline

Start date
2009-12-01
Primary completion
2010-04-01
Completion
2010-04-01
First posted
2010-04-08
Last updated
2010-04-08

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01099865. Inclusion in this directory is not an endorsement.